C81.79
Other Hodgkin lymphoma, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Other Hodgkin lymphoma, classified under ICD-10 code C81.79, refers to a form of Hodgkin lymphoma that affects areas outside the lymph nodes or involves solid organs. Hodgkin lymphoma is a type of cancer originating from lymphocytes, the cells involved in the immune response. This particular classification pertains to cases where the disease manifests in atypical locations, such as organs outside the lymphatic system. Recognizing the differences in presentation is key for diagnosis and treatment planning, highlighting the importance of understanding this specific subset of Hodgkin lymphoma.
Causes & Symptoms
Clinical Causes: Genetic predispositions that may increase risk Previous exposure to certain infectious agents, like Epstein-Barr virus Family history of lymphomas or other cancers Weakened immune system conditions, such as HIV/AIDS Environmental factors, including exposure to certain chemicals
Key Symptoms: Swelling or painless lumps in the neck, chest, or underarms Unexplained weight loss Persistent fatigue or weakness Fever that comes and goes Night sweats, often severe Itching all over the body Pain or discomfort in affected organs Breathlessness or cough if the lungs are involved Abdominal pain or swelling if the abdomen is affected
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other Hodgkin lymphoma affecting extranodal and solid organ sites involves several clinical steps. Initially, a detailed medical history and physical exam are performed to identify abnormal lumps or symptoms. Imaging studies, such as CT scans and PET scans, help visualize the spread and specific locations of the disease. A biopsy, often guided by imaging, is necessary to confirm the diagnosis by examining tissue samples microscopically. Additional tests, including blood work and bone marrow biopsies, may be conducted to assess the extent of disease involvement and overall health status.
Treatment Protocols: Chemotherapy: Systemic drugs to kill cancer cells, often involving regimens like ABVD (adriamycin, bleomycin, vinblastine, dacarbazine). Radiation therapy: Targeted radiation to affected areas, especially in localized disease. Immunotherapy: Utilization of agents that help the immune system recognize and attack cancer cells. Stem cell transplant: Used in cases where the disease is resistant or relapses after initial treatment. Clinical trials: Participation in research studies exploring new therapies or combinations.
Clinical Advice & FAQs
Billing Guidance
Is C81.79 a billable ICD-10 code?
Yes, C81.79 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.79?
Clinical documentation must specify the nature of Other Hodgkin lymphoma, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference